ZCMD

Commercial Services
$0.17 -69.09%
Back to Screener
Live Volume
163,767,036
Market Cap
643,741
P/E Ratio
-
52W Peak Proximity
%1

ANALYSIS CENTER

AI Rating & Analysis: ZCMD stock analysis with hallucination-free AI screener tools — real-time price, volume, P/E ratio, 52-week proximity and sector performance data for Commercial Services. AI-powered stock analysis and research platform.
GOD-TIER PROMPT ACTIVE
Investment report at Goldman Sachs + Bridgewater + Renaissance Technologies level
10 sections: Tables • Charts • Bullet Points. Plain text PROHIBITED.
1Executive Summary
2Fair Value
3Fundamental Analysis
4Technical Analysis
5Scenario Analysis
6Competitor Comparison
7Dividend Return
8Risk Analysis
9Catalyst Calendar
10Action Plan
HOW IT WORKS: When you click an AI button below, this prompt is instantly copied to your clipboard. Simply Paste (CTRL+V) it into the chat box of the opened AI assistant to run the analysis.
İpucu: Tip: Use our TradingView charts for technical analysis. Evaluate alongside the AI report.
Open Advanced Chart
TradingView Charts
• 15-min delayed price feed • 100+ technical indicators • Sub-second updates • Professional drawing tools
Affiliate links — DocuRefinery may earn a commission when you open an account.

Interactive Brokers

SEC, FINRA, FCA, ASIC Regulation $0 Min. Deposit
Access 150+ global markets. Stocks, ETFs, Options, Futures, Forex.
Open Account

TD Ameritrade (Schwab)

SEC, FINRA Regulation $0 Min. Deposit
Industry-leading trading platforms and comprehensive education.
Open Account
All investing involves risk, including the possible loss of principal. Past performance does not guarantee future results.

Latest News — ZCMD

Zhongchao Inc. — Company Profile & Analysis

Zhongchao Inc., founded in 2012 and headquartered in the bustling metropolis of Shanghai, China, has rapidly established itself as a pivotal player in the digital healthcare ecosystem. The company's core mission revolves around empowering healthcare professionals across the People's Republic of China by providing comprehensive healthcare information, education, and training services. Operating primarily under its well-recognized MDMOOC brand, Zhongchao Inc. aims to bridge the knowledge gap, facilitate continuous professional development, and ultimately contribute to the enhancement of patient care and public health outcomes throughout the nation. Its founding vision was to leverage technology to democratize access to high-quality medical education and specialized knowledge, addressing the evolving needs of a dynamic healthcare landscape.

The company's operational framework is segmented into two primary areas: MDMOOC services and the Sales of Patented Drugs. The MDMOOC services segment is particularly robust, encompassing a wide array of offerings designed to support healthcare professionals and patients alike. This includes specialized patient management services, particularly in the critical fields of tumor and rare diseases, delivered through dedicated IT systems under the Zhongxun brand, as well as via popular platforms like WeChat mini programs (Zhongxin Health). Furthermore, Zhongchao Inc. provides internet healthcare services, pharmaceutical services, and operates an extensive online information platform. Its educational portfolio is diverse, offering both online and onsite health information services, comprehensive healthcare education programs, and practical training products. These programs range from clinical practice training, open classes on popular medical topics, and interactive case studies to academic conferences, workshops, and continuing education courses, supplemented by a rich library of articles and short videos with educational healthcare content. The delivery of these services is primarily facilitated through its sophisticated MDMOOC online platform, which includes a mobile app, the MOOC Medical WeChat subscription account, and the MDMOOC website, showcasing a strong commitment to digital innovation and accessibility.

Zhongchao Inc. holds a significant market position within China's burgeoning digital medical education and professional development sector. Its target demographics are broad yet focused, serving a diverse clientele that includes pharmaceutical enterprises, non-profit organizations such such as medical associations, medical institutions, medical journals, medical foundations, and hospitals, alongside individual healthcare professionals, nurses, and doctors. By integrating educational content with patient management solutions and pharmaceutical services, the company has cultivated a comprehensive ecosystem that addresses multiple facets of the healthcare value chain. While its primary geographical focus remains the People's Republic of China, its digital-first approach inherently allows for scalable reach within this vast market, positioning it as a key enabler for continuous learning and specialized knowledge dissemination among a large and growing professional base.

Looking ahead, Zhongchao Inc. is strategically positioned for sustained growth, driven by the increasing demand for specialized medical knowledge and continuous professional development in China, further bolstered by supportive government policies for healthcare modernization. The company's future outlook involves a continued expansion of its content offerings, with a focus on deepening its expertise in high-demand therapeutic areas like oncology and rare diseases. Strategic directions include enhancing its platform technology through potential integration of advanced analytics and artificial intelligence for personalized learning experiences, strengthening its collaborative partnerships with leading pharmaceutical companies and medical institutions, and broadening the reach and efficacy of its patient management solutions. By consistently innovating and adapting to the evolving needs of the Chinese healthcare market, Zhongchao Inc. aims to solidify its leadership in digital medical education and patient support, driving improved health outcomes nationwide.

Economic Moat Zhongchao Inc. benefits from a robust sustainable competitive advantage rooted in its extensive network and deep partnerships with key stakeholders across the Chinese healthcare ecosystem, including medical institutions, pharmaceutical companies, and a vast community of healthcare professionals. Its proprietary MDMOOC online platform, coupled with integrated patient management systems like Zhongxun, creates a sticky and comprehensive digital ecosystem that fosters high user engagement and retention. Furthermore, the company's specialized content and services, particularly in high-demand and complex areas such as tumor and rare diseases, establish a strong reputation for expertise and trust, making it a preferred partner and resource for medical professionals seeking advanced knowledge and support.
CEO Mr. Weiguang Yang
Employees 33
Headquarters China
Market Competitors
Smart Tags
#HealthcareTech #MedicalEducation #ChinaMarket #DigitalHealth #ProfessionalDevelopment #PatientManagement #ZCMD #PharmaceuticalServices

Market Insights & Investor Q&A — ZCMD

Frequently Asked Questions

How can I use a prompt to analyze a ticker like ZCMD?
You should choose a prompt that incorporates AI techniques such as risk analysis, trend detection, and balance‑sheet scanning. On DocuRefinery you can find ready‑made and instant prompt options that are free and require no signup. These prompts work with verified data and deliver hallucination‑free results.
Are there free prompt templates that don’t require any signup?
Yes, DocuRefinery offers free (free) prompt templates that need no signup (no signup) and you don’t have to complete any no registration (no registration) process. You can start using ready‑made (ready-made) and template (template) options instantly (instant) without any barriers.
How can I verify that the AI output is hallucination‑free and based on reliable data?
To ensure the output is hallucination‑free, check that the model is fed with verified data (verified data) and that the prompt is designed to limit speculative generation. When the prompt is crafted correctly, the result will be hallucination‑free (hallucination-free) and trustworthy.

Deep Analysis

AI-Powered Ready Solutions for ZCMD Investment Analysis

Analyzing tickers with AI involves applying risk analysis, trend detection, and balance‑sheet scanning using natural language processing and statistical models. These techniques enable faster and more objective insights.

DocuRefinery provides ready‑made (ready-made) and instant (instant) prompts that are free (free) and require no signup (no signup). Users can access them without any no registration (no registration) step, and the underlying models rely on verified data (verified data) to produce hallucination‑free (hallucination-free) outputs.

Compared with traditional analysis, which can be time‑consuming and prone to human bias, the ready‑made prompt approach offers a practical shortcut. By tweaking the prompt, investors can tailor the analysis to specific strategies and obtain deeper, more actionable results.